News

AN2 Therapeutics Reports Key Insights from 200-Patient Observational Study in Acute Melioidosis, Laying Groundwork for Phase 2 Proof-of-Concept Trial of Epetraborole ...
Acute exacerbations of chronic bronchitis can be triggered by air pollutants, allergens, irritants (e.g., dust, cigarette smoke), temperature changes and infectious agents (viral and bacterial ...
The respiratory fluoroquinolones include levofloxacin, moxifloxacin and gemifloxacin and have been recommended as a first-line treatment for AECB in patients who have chronic bronchitis ...